News

Medscape3d
Cardiac Dysfunction Surfaces Early With Cancer Treatment
Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.
Pharmaceutical Technology on MSN2d
FDA approves Biocon Biologics’ bevacizumab biosimilar for cancer
Biocon Biologics has gained approval from the US Food and Drug Administration (FDA) for the intravenous use of Jobevne ...
Fierce Biotech3d
Opthea lays off 65% of staff after back-to-back phase 3 eye disease flops
Opthea’s staff are paying for its clinical failures. Days after back-to-back flops sank an eye disease asset, the biotech ...
New Clue in Alzheimer’s: It Might Be in Your Blood Vessels, Not Just Your Brain
The interaction between the brain and the vascular system could hold the key to lowering disease risk. According to the Alzheimer Society of Canada, one in four Canadians over the age of 85 is living ...
CURE3d
FDA Approves Avastin Biosimilar Jobevne Across Several Cancer Types
The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...
Drug Store News3d
Biocon Biologics obtains FDA nod for Avastin biosimilar
Biocon Biologics has received the Food and Drug Administration’s green light for Jobevne (bevacizumab-nwgd), a biosimilar ...
AHA/ASA Journals12d
Lymphatic Endothelial Branched-Chain Amino Acid Catabolic Defects Undermine Cardiac Lymphatic Integrity and Drive HFpEF
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but effective treatments are lacking. Cardiac lymphatics play a crucial role in ...